ArticleInternational journal of biological sciences2024

Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway.

Boshen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.